Talecris Biotherapeutics to Report First Quarter 2011 Financial Results
14 Abril 2011 - 8:27AM
PR Newswire (US)
RESEARCH TRIANGLE PARK, N.C.,
April 14, 2011 /PRNewswire/ --
Talecris Biotherapeutics Holdings Corp. (NASDAQ: TLCR) will issue
its first quarter earnings release after the market closes on
April 27, 2011. Due to the pending
merger with Grifols, S.A., Talecris will not be hosting a
conference call to discuss its first quarter results.
About Talecris Biotherapeutics: Inspiration.
Dedication. Innovation.
Talecris Biotherapeutics is a global biotherapeutic and
biotechnology company that discovers, develops and produces
critical care treatments for people with life-threatening disorders
in a variety of therapeutic areas including immunology,
pulmonology, neurology and hemostasis. For more information, please
visit: www.talecris.com.
SOURCE Talecris Biotherapeutics, Inc.
Copyright 2011 PR Newswire
Talecris Biotherapeutics Holdings Corp. (MM) (NASDAQ:TLCR)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Talecris Biotherapeutics Holdings Corp. (MM) (NASDAQ:TLCR)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Talecris Biotherapeutics Holdings Corp. (MM) (NASDAQ): 0 recent articles
Más de Talecris Biotherapeutics Holdings Corp. (MM) Artículos de Noticias